"Famotidine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Descriptor ID |
D015738
|
| MeSH Number(s) |
D02.886.675.215 D03.383.129.708.215
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Famotidine".
Below are MeSH descriptors whose meaning is more specific than "Famotidine".
This graph shows the total number of publications written about "Famotidine" by people in this website by year, and whether "Famotidine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Famotidine" by people in Profiles.
-
No evidence of clinical efficacy of famotidine for the treatment of COVID-19: a systematic review and meta-analysis. J Infect. 2023 02; 86(2):154-225.
-
Pharmacokinetics of famotidine in infants. Clin Pharmacokinet. 2005; 44(4):395-406.
-
False negative urea breath tests with H2-receptor antagonists: interactions between Helicobacter pylori density and pH. Helicobacter. 2004 Feb; 9(1):17-27.
-
Comparison of the effect of intermittent administration and continuous infusion of famotidine on gastric pH in critically ill patients: results of a prospective, randomized, crossover study. Crit Care Med. 1995 Apr; 23(4):687-91.
-
Suppression of nocturnal acid secretion with famotidine accelerates gastric ulcer healing. Gastroenterology. 1989 Oct; 97(4):860-6.
-
Famotidine, a new H2-receptor antagonist. Effect on parietal, nonparietal, and pepsin secretion in man. Dig Dis Sci. 1985 Apr; 30(4):308-12.